Dudediligence.

Corbus Pharmaceuticals Holdings, Inc

CRBPNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$2,058,285

7 notices · 118,736 sh

Oct 2025 to Oct 2026

Reported ·

$1,378,534

14 sales · 2 buys · $101,205 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

9 of 14 reported sales carry the 10b5-1 box. Together they are 0.58% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-08-07: Stifel, Nicolaus & Company, Inc CIAS /FA, Form 1442026-08-07: Stifel, Nicolaus & Company, Inc CIAS /FA, Form 1442026-07-27: Smethurst Dominic, Form 1442026-03-02: Smethurst Dominic, Form 1442026-02-13: Cohen Yuval, Form 1442025-10-24: Cohen Yuval, Form 1442025-10-24: Moran Sean F., Form 1442025-10-20: Altmeyer Anne, sold2025-10-24: Moran Sean F., sold2025-10-24: Cohen Yuval, sold2025-12-11: Cormorant Asset Management, LP, sold2026-02-03: Hodgson Ian, sold2026-02-03: Smethurst Dominic, sold2026-02-13: Cohen Yuval, sold2026-02-13: Moran Sean F., sold2026-02-17: Hodgson Ian, sold2026-03-02: Smethurst Dominic, sold2026-06-02: Saxena Nishant C, bought2026-06-10: Altmeyer Anne, sold2026-06-10: Jenkins John Kenneth, sold2026-06-10: Kung Winston, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-08-07Stifel, Nicolaus & Company, Inc CIAS /FA, Officer$120,971
12,000 shplan 2026-03-11Form 4s on file end Jun 23144 ↗
2026-08-07Stifel, Nicolaus & Company, Inc CIAS /FA, Officer$171,396
17,000 shplan 2026-03-11Form 4s on file end Jun 23144 ↗
2026-07-27Smethurst Dominic, Chief Medical Officer$211,818
23,025 shno plan dateForm 4s on file end Jun 23144 ↗
2026-03-02Smethurst Dominic, Chief Medical Officer$50,601
6,097 shno plan date144 ↗
Form 4, 2026-03-04: sold 6,097 at $8.30 Form 4 ↗
2026-02-13Cohen Yuval, Chief Executive Officer$812,600
20,000 shplan 2025-03-14144 ↗
Form 4, 2026-02-18: sold 13,871 at $7.78 Form 4 ↗
2025-10-24Cohen Yuval, Chief Executive Officer$469,977
27,633 shplan 2025-03-14144 ↗
Form 4, 2025-10-27: sold 27,633 at $17.05 Form 4 ↗
2025-10-24Moran Sean F., Chief Financial Officer$220,922
12,981 shplan 2025-03-14144 ↗
Form 4, 2025-10-27: sold 12,981 at $17.02 Form 4 ↗